EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - TSX:EXE - CA30224T8639 - Common Stock
15.82 CAD
-0.08 (-0.5%)
Overall EXE gets a fundamental rating of 6 out of 10. We evaluated EXE against 15 industry peers in the Health Care Providers & Services industry. While EXE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on EXE. These ratings would make EXE suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
In the past 5 years EXE has always been profitable.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE has a Return On Assets of 10.69%. This is amongst the best in the industry. EXE outperforms 86.67% of its industry peers.
EXE has a better Return On Equity (55.86%) than 93.33% of its industry peers.
EXE has a Return On Invested Capital of 19.22%. This is amongst the best in the industry. EXE outperforms 100.00% of its industry peers.
EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 7.83%.
The last Return On Invested Capital (19.22%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROIC | 19.22% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
EXE has a Profit Margin of 5.51%. This is in the better half of the industry: EXE outperforms 73.33% of its industry peers.
EXE's Profit Margin has improved in the last couple of years.
The Operating Margin of EXE (7.78%) is better than 73.33% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 13.86%, EXE is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EXE has more shares outstanding than it did 1 year ago.
EXE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for EXE has been reduced compared to a year ago.
2.2 Solvency
EXE has an Altman-Z score of 3.04. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
EXE has a Altman-Z score of 3.04. This is in the better half of the industry: EXE outperforms 80.00% of its industry peers.
The Debt to FCF ratio of EXE is 3.60, which is a good value as it means it would take EXE, 3.60 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.60, EXE is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
A Debt/Equity ratio of 1.79 is on the high side and indicates that EXE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.79, EXE is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Altman-Z | 3.04 |
ROIC/WACC2.39
WACC8.04%
2.3 Liquidity
A Current Ratio of 0.85 indicates that EXE may have some problems paying its short term obligations.
EXE's Current ratio of 0.85 is in line compared to the rest of the industry. EXE outperforms 60.00% of its industry peers.
A Quick Ratio of 0.85 indicates that EXE may have some problems paying its short term obligations.
EXE has a Quick ratio of 0.85. This is in the better half of the industry: EXE outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 46.37% over the past year.
Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.68%.
The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
3.2 Future
EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
Based on estimates for the next years, EXE will show a small growth in Revenue. The Revenue will grow by 5.51% on average per year.
EPS Next Y25%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
EPS Next 5Y8.04%
Revenue Next Year11.08%
Revenue Next 2Y8.8%
Revenue Next 3Y6.78%
Revenue Next 5Y5.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.01, the valuation of EXE can be described as rather expensive.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 86.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.19. EXE is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.80, which indicates a correct valuation of EXE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 93.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, EXE is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.01 | ||
| Fwd PE | 16.8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EXE is valued cheaper than 86.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EXE is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.8 | ||
| EV/EBITDA | 10.17 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)0.68
PEG (5Y)0.75
EPS Next 2Y8.65%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 3.13%. Purely for dividend investing, there may be better candidates out there.
EXE's Dividend Yield is rather good when compared to the industry average which is at 3.09. EXE pays more dividend than 86.67% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, EXE pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EXE pays out 48.82% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.82%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
TSX:EXE (10/30/2025, 7:00:00 PM)
15.82
-0.08 (-0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners27.27%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.33B
Revenue(TTM)1.51B
Net Income(TTM)83.18M
Analysts75
Price Target16.84 (6.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.13% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP48.82%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)2.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)30.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.01 | ||
| Fwd PE | 16.8 | ||
| P/S | 0.88 | ||
| P/FCF | 16.8 | ||
| P/OCF | 10.09 | ||
| P/B | 8.91 | ||
| P/tB | 40.21 | ||
| EV/EBITDA | 10.17 |
EPS(TTM)0.93
EY5.88%
EPS(NY)0.94
Fwd EY5.95%
FCF(TTM)0.94
FCFY5.95%
OCF(TTM)1.57
OCFY9.91%
SpS18
BVpS1.78
TBVpS0.39
PEG (NY)0.68
PEG (5Y)0.75
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| ROCE | 25.43% | ||
| ROIC | 19.22% | ||
| ROICexc | 22.81% | ||
| ROICexgc | 32.51% | ||
| OM | 7.78% | ||
| PM (TTM) | 5.51% | ||
| GM | 13.86% | ||
| FCFM | 5.23% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.94
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.79 | ||
| Debt/FCF | 3.6 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 154.92% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 10.8 | ||
| Cash Conversion | 86.92% | ||
| Profit Quality | 94.89% | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 3.04 |
F-Score6
WACC8.04%
ROIC/WACC2.39
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.37%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%37.31%
EPS Next Y25%
EPS Next 2Y8.65%
EPS Next 3Y5.59%
EPS Next 5Y8.04%
Revenue 1Y (TTM)8.68%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%10.03%
Revenue Next Year11.08%
Revenue Next 2Y8.8%
Revenue Next 3Y6.78%
Revenue Next 5Y5.51%
EBIT growth 1Y39.21%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-0.49%
EBIT Next 3Y2.81%
EBIT Next 5Y2.58%
FCF growth 1Y179.71%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y406.79%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
Can you provide the valuation status for EXTENDICARE INC?
ChartMill assigns a valuation rating of 7 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Undervalued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for EXE stock?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 17.01 and the Price/Book (PB) ratio is 8.91.
What is the financial health of EXTENDICARE INC (EXE.CA) stock?
The financial health rating of EXTENDICARE INC (EXE.CA) is 5 / 10.